The 2021 Dutch Working Party on Antibiotic Policy (SWAB) guidelines for empirical antibacterial therapy of sepsis in adults

Abstract Background The Dutch Working Party on Antibiotic Policy (SWAB) in collaboration with relevant professional societies, has updated their evidence-based guidelines on empiric antibacterial therapy of sepsis in adults. Methods Our multidisciplinary guideline committee generated ten population,...

Full description

Bibliographic Details
Main Authors: Elske Sieswerda, Hannelore I. Bax, Jacobien J. Hoogerwerf, Mark G. J. de Boer, Marja Boermeester, Marc J. M. Bonten, Douwe Dekker, Roy Gerth van Wijk, Nicole P. Juffermans, Marnix Kuindersma, Paul D. van der Linden, Damian C. Melles, Peter Pickkers, Jeroen A. Schouten, Jasper R. Rebel, Arthur R. H. van Zanten, Jan M. Prins, W. Joost Wiersinga
Format: Article
Language:English
Published: BMC 2022-08-01
Series:BMC Infectious Diseases
Subjects:
Online Access:https://doi.org/10.1186/s12879-022-07653-3
_version_ 1828154281291677696
author Elske Sieswerda
Hannelore I. Bax
Jacobien J. Hoogerwerf
Mark G. J. de Boer
Marja Boermeester
Marc J. M. Bonten
Douwe Dekker
Roy Gerth van Wijk
Nicole P. Juffermans
Marnix Kuindersma
Paul D. van der Linden
Damian C. Melles
Peter Pickkers
Jeroen A. Schouten
Jasper R. Rebel
Arthur R. H. van Zanten
Jan M. Prins
W. Joost Wiersinga
author_facet Elske Sieswerda
Hannelore I. Bax
Jacobien J. Hoogerwerf
Mark G. J. de Boer
Marja Boermeester
Marc J. M. Bonten
Douwe Dekker
Roy Gerth van Wijk
Nicole P. Juffermans
Marnix Kuindersma
Paul D. van der Linden
Damian C. Melles
Peter Pickkers
Jeroen A. Schouten
Jasper R. Rebel
Arthur R. H. van Zanten
Jan M. Prins
W. Joost Wiersinga
author_sort Elske Sieswerda
collection DOAJ
description Abstract Background The Dutch Working Party on Antibiotic Policy (SWAB) in collaboration with relevant professional societies, has updated their evidence-based guidelines on empiric antibacterial therapy of sepsis in adults. Methods Our multidisciplinary guideline committee generated ten population, intervention, comparison, and outcome (PICO) questions relevant for adult patients with sepsis. For each question, a literature search was performed to obtain the best available evidence and assessed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system. The quality of evidence for clinically relevant outcomes was graded from high to very low. In structured consensus meetings, the committee formulated recommendations as strong or weak. When evidence could not be obtained, recommendations were provided based on expert opinion and experience (good practice statements). Results Fifty-five recommendations on the antibacterial therapy of sepsis were generated. Recommendations on empiric antibacterial therapy choices were differentiated for sepsis according to the source of infection, the potential causative pathogen and its resistance pattern. One important revision was the distinction between low, increased and high risk of infection with Enterobacterales resistant to third generation cephalosporins (3GRC-E) to guide the choice of empirical therapy. Other new topics included empirical antibacterial therapy in patients with a reported penicillin allergy and the role of pharmacokinetics and pharmacodynamics to guide dosing in sepsis. We also established recommendations on timing and duration of antibacterial treatment. Conclusions Our multidisciplinary committee formulated evidence-based recommendations for the empiric antibacterial therapy of adults with sepsis in The Netherlands.
first_indexed 2024-04-11T22:36:32Z
format Article
id doaj.art-428bc82ef7f045c2b74f25abb5e6bb8a
institution Directory Open Access Journal
issn 1471-2334
language English
last_indexed 2024-04-11T22:36:32Z
publishDate 2022-08-01
publisher BMC
record_format Article
series BMC Infectious Diseases
spelling doaj.art-428bc82ef7f045c2b74f25abb5e6bb8a2022-12-22T03:59:11ZengBMCBMC Infectious Diseases1471-23342022-08-0122111610.1186/s12879-022-07653-3The 2021 Dutch Working Party on Antibiotic Policy (SWAB) guidelines for empirical antibacterial therapy of sepsis in adultsElske Sieswerda0Hannelore I. Bax1Jacobien J. Hoogerwerf2Mark G. J. de Boer3Marja Boermeester4Marc J. M. Bonten5Douwe Dekker6Roy Gerth van Wijk7Nicole P. Juffermans8Marnix Kuindersma9Paul D. van der Linden10Damian C. Melles11Peter Pickkers12Jeroen A. Schouten13Jasper R. Rebel14Arthur R. H. van Zanten15Jan M. Prins16W. Joost Wiersinga17Department of Medical Microbiology, University Medical Centre Utrecht, Utrecht UniversityDepartment of Internal Medicine, Section of Infectious Diseases and Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical CenterDepartment of Medicine, Radboud Center for Infectious Diseases, Radboud University Medical CenterDepartment of Infectious Diseases, Leiden University Medical CenterDepartment of Surgery, Amsterdam UMC, University of AmsterdamJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht UniversityDepartment of Internal Medicine, University Medical Centre UtrechtDivision of Allergology, Department of Internal Medicine, Erasmus Medical CenterDepartment of Intensive Care, OLVG HospitalDepartment of Intensive Care, Gelre ziekenhuis ApeldoornDepartment of Clinical Pharmacy, Tergooi HospitalDepartment of Medical Microbiology and Immunology, Meander Medical CenterDepartment of Intensive Care Medicine, Radboud Center for Infectious Diseases, Radboud University Medical CenterDepartment of Intensive Care Medicine, Radboud Center for Infectious Diseases, Radboud University Medical CenterDepartment of Emergency Medicine, OLVG HospitalDepartment of Intensive Care Medicine, Ziekenhuis Gelderse ValleiDivision of Infectious Diseases, Department of Medicine, Amsterdam UMC, University of AmsterdamDivision of Infectious Diseases, Department of Medicine, Amsterdam UMC, University of AmsterdamAbstract Background The Dutch Working Party on Antibiotic Policy (SWAB) in collaboration with relevant professional societies, has updated their evidence-based guidelines on empiric antibacterial therapy of sepsis in adults. Methods Our multidisciplinary guideline committee generated ten population, intervention, comparison, and outcome (PICO) questions relevant for adult patients with sepsis. For each question, a literature search was performed to obtain the best available evidence and assessed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system. The quality of evidence for clinically relevant outcomes was graded from high to very low. In structured consensus meetings, the committee formulated recommendations as strong or weak. When evidence could not be obtained, recommendations were provided based on expert opinion and experience (good practice statements). Results Fifty-five recommendations on the antibacterial therapy of sepsis were generated. Recommendations on empiric antibacterial therapy choices were differentiated for sepsis according to the source of infection, the potential causative pathogen and its resistance pattern. One important revision was the distinction between low, increased and high risk of infection with Enterobacterales resistant to third generation cephalosporins (3GRC-E) to guide the choice of empirical therapy. Other new topics included empirical antibacterial therapy in patients with a reported penicillin allergy and the role of pharmacokinetics and pharmacodynamics to guide dosing in sepsis. We also established recommendations on timing and duration of antibacterial treatment. Conclusions Our multidisciplinary committee formulated evidence-based recommendations for the empiric antibacterial therapy of adults with sepsis in The Netherlands.https://doi.org/10.1186/s12879-022-07653-3Antibacterial therapyDuration of antibiotic therapySepsisGuidelinesEmpirical therapyPharmacokinetics
spellingShingle Elske Sieswerda
Hannelore I. Bax
Jacobien J. Hoogerwerf
Mark G. J. de Boer
Marja Boermeester
Marc J. M. Bonten
Douwe Dekker
Roy Gerth van Wijk
Nicole P. Juffermans
Marnix Kuindersma
Paul D. van der Linden
Damian C. Melles
Peter Pickkers
Jeroen A. Schouten
Jasper R. Rebel
Arthur R. H. van Zanten
Jan M. Prins
W. Joost Wiersinga
The 2021 Dutch Working Party on Antibiotic Policy (SWAB) guidelines for empirical antibacterial therapy of sepsis in adults
BMC Infectious Diseases
Antibacterial therapy
Duration of antibiotic therapy
Sepsis
Guidelines
Empirical therapy
Pharmacokinetics
title The 2021 Dutch Working Party on Antibiotic Policy (SWAB) guidelines for empirical antibacterial therapy of sepsis in adults
title_full The 2021 Dutch Working Party on Antibiotic Policy (SWAB) guidelines for empirical antibacterial therapy of sepsis in adults
title_fullStr The 2021 Dutch Working Party on Antibiotic Policy (SWAB) guidelines for empirical antibacterial therapy of sepsis in adults
title_full_unstemmed The 2021 Dutch Working Party on Antibiotic Policy (SWAB) guidelines for empirical antibacterial therapy of sepsis in adults
title_short The 2021 Dutch Working Party on Antibiotic Policy (SWAB) guidelines for empirical antibacterial therapy of sepsis in adults
title_sort 2021 dutch working party on antibiotic policy swab guidelines for empirical antibacterial therapy of sepsis in adults
topic Antibacterial therapy
Duration of antibiotic therapy
Sepsis
Guidelines
Empirical therapy
Pharmacokinetics
url https://doi.org/10.1186/s12879-022-07653-3
work_keys_str_mv AT elskesieswerda the2021dutchworkingpartyonantibioticpolicyswabguidelinesforempiricalantibacterialtherapyofsepsisinadults
AT hanneloreibax the2021dutchworkingpartyonantibioticpolicyswabguidelinesforempiricalantibacterialtherapyofsepsisinadults
AT jacobienjhoogerwerf the2021dutchworkingpartyonantibioticpolicyswabguidelinesforempiricalantibacterialtherapyofsepsisinadults
AT markgjdeboer the2021dutchworkingpartyonantibioticpolicyswabguidelinesforempiricalantibacterialtherapyofsepsisinadults
AT marjaboermeester the2021dutchworkingpartyonantibioticpolicyswabguidelinesforempiricalantibacterialtherapyofsepsisinadults
AT marcjmbonten the2021dutchworkingpartyonantibioticpolicyswabguidelinesforempiricalantibacterialtherapyofsepsisinadults
AT douwedekker the2021dutchworkingpartyonantibioticpolicyswabguidelinesforempiricalantibacterialtherapyofsepsisinadults
AT roygerthvanwijk the2021dutchworkingpartyonantibioticpolicyswabguidelinesforempiricalantibacterialtherapyofsepsisinadults
AT nicolepjuffermans the2021dutchworkingpartyonantibioticpolicyswabguidelinesforempiricalantibacterialtherapyofsepsisinadults
AT marnixkuindersma the2021dutchworkingpartyonantibioticpolicyswabguidelinesforempiricalantibacterialtherapyofsepsisinadults
AT pauldvanderlinden the2021dutchworkingpartyonantibioticpolicyswabguidelinesforempiricalantibacterialtherapyofsepsisinadults
AT damiancmelles the2021dutchworkingpartyonantibioticpolicyswabguidelinesforempiricalantibacterialtherapyofsepsisinadults
AT peterpickkers the2021dutchworkingpartyonantibioticpolicyswabguidelinesforempiricalantibacterialtherapyofsepsisinadults
AT jeroenaschouten the2021dutchworkingpartyonantibioticpolicyswabguidelinesforempiricalantibacterialtherapyofsepsisinadults
AT jasperrrebel the2021dutchworkingpartyonantibioticpolicyswabguidelinesforempiricalantibacterialtherapyofsepsisinadults
AT arthurrhvanzanten the2021dutchworkingpartyonantibioticpolicyswabguidelinesforempiricalantibacterialtherapyofsepsisinadults
AT janmprins the2021dutchworkingpartyonantibioticpolicyswabguidelinesforempiricalantibacterialtherapyofsepsisinadults
AT wjoostwiersinga the2021dutchworkingpartyonantibioticpolicyswabguidelinesforempiricalantibacterialtherapyofsepsisinadults
AT elskesieswerda 2021dutchworkingpartyonantibioticpolicyswabguidelinesforempiricalantibacterialtherapyofsepsisinadults
AT hanneloreibax 2021dutchworkingpartyonantibioticpolicyswabguidelinesforempiricalantibacterialtherapyofsepsisinadults
AT jacobienjhoogerwerf 2021dutchworkingpartyonantibioticpolicyswabguidelinesforempiricalantibacterialtherapyofsepsisinadults
AT markgjdeboer 2021dutchworkingpartyonantibioticpolicyswabguidelinesforempiricalantibacterialtherapyofsepsisinadults
AT marjaboermeester 2021dutchworkingpartyonantibioticpolicyswabguidelinesforempiricalantibacterialtherapyofsepsisinadults
AT marcjmbonten 2021dutchworkingpartyonantibioticpolicyswabguidelinesforempiricalantibacterialtherapyofsepsisinadults
AT douwedekker 2021dutchworkingpartyonantibioticpolicyswabguidelinesforempiricalantibacterialtherapyofsepsisinadults
AT roygerthvanwijk 2021dutchworkingpartyonantibioticpolicyswabguidelinesforempiricalantibacterialtherapyofsepsisinadults
AT nicolepjuffermans 2021dutchworkingpartyonantibioticpolicyswabguidelinesforempiricalantibacterialtherapyofsepsisinadults
AT marnixkuindersma 2021dutchworkingpartyonantibioticpolicyswabguidelinesforempiricalantibacterialtherapyofsepsisinadults
AT pauldvanderlinden 2021dutchworkingpartyonantibioticpolicyswabguidelinesforempiricalantibacterialtherapyofsepsisinadults
AT damiancmelles 2021dutchworkingpartyonantibioticpolicyswabguidelinesforempiricalantibacterialtherapyofsepsisinadults
AT peterpickkers 2021dutchworkingpartyonantibioticpolicyswabguidelinesforempiricalantibacterialtherapyofsepsisinadults
AT jeroenaschouten 2021dutchworkingpartyonantibioticpolicyswabguidelinesforempiricalantibacterialtherapyofsepsisinadults
AT jasperrrebel 2021dutchworkingpartyonantibioticpolicyswabguidelinesforempiricalantibacterialtherapyofsepsisinadults
AT arthurrhvanzanten 2021dutchworkingpartyonantibioticpolicyswabguidelinesforempiricalantibacterialtherapyofsepsisinadults
AT janmprins 2021dutchworkingpartyonantibioticpolicyswabguidelinesforempiricalantibacterialtherapyofsepsisinadults
AT wjoostwiersinga 2021dutchworkingpartyonantibioticpolicyswabguidelinesforempiricalantibacterialtherapyofsepsisinadults